TELOMERASE IN UROLOGICAL MALIGNANCY
- 1 August 2001
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 166 (2) , 666-673
- https://doi.org/10.1016/s0022-5347(05)66040-5
Abstract
Conclusions Larger perspective studies of larger groups of patients are required to discover an appropriate role for telomerase when assessing these tumors. The improvement of quantitative methods to evaluate the expression of telomerase is a cornerstone in the complete clarification of the clinical relevance of telomerase.Keywords
This publication has 95 references indexed in Scilit:
- The 5′-End of hTERT mRNA Is a Good Target for Hammerhead Ribozyme to Suppress Telomerase ActivityBiochemical and Biophysical Research Communications, 2000
- htert expression correlates withMYC over-expression in human prostate cancerInternational Journal of Cancer, 2000
- Telomerase activity as a potential marker in preneoplastic bladder lesionsBJU International, 2000
- Telomerase activity in patients with transitional cell carcinomaCancer, 1999
- Cellular senescence and cancerThe Journal of Pathology, 1999
- Detection of Telomerase Activity in Chinese Hamster V79 Cells and Its Inhibition by 7-Deaza-deoxy Guanosine Triphosphate and (TTAGGG)4in VitroBiochemical and Biophysical Research Communications, 1998
- Irreversible Telomere Shortening by 3′-Azido-2′, 3′-Dideoxythymidine (AZT) TreatmentBiochemical and Biophysical Research Communications, 1998
- Multiple pathways for the regulation of telomerase activityEuropean Journal Of Cancer, 1997
- Hammerhead Ribozyme-Mediated Inhibition of Telomerase Activity in Extracts of Human Hepatocellular Carcinoma CellsBiochemical and Biophysical Research Communications, 1996
- Reverse transcriptase inhibitors suppress telomerase function and induce senescence‐like processes in cultured mouse fibroblastsFEBS Letters, 1996